参考文献/References:
[1] AKKAWI I, ZMERLY H.Osteoporosis:current concepts[J].Joints,2018,6(2):122-127.
[2] SKJODT M K.Side effects of drugs for osteoporosis and metastatic bone disease[J].Br J Clin Pharmacol,2018,85(6):1063-1071.
[3] PAOLUCCI T,SARACENI V M,PICCININI G.Management of chronic pain in osteoporosis:challenges and solutions[J].Pain Res,2016,9:177-186.
[4] 位新维,陈志信.对骨质疏松性慢性疼痛:如何认知和预防?[J].中国组织工程研究,2014,18(38):6194-6199.
[5] URUSHIHARA H,YOH K,HAMAYA E,et al.Responsiveness of the Japanese osteoporosis quality of life questionnaire in women with postmenopausal osteoporosis [J].Health Qual Life Outcomes,2014,12:178.
[6] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[7] ZIGMOND A S, SNAITH R P.The hospital anxiety and depression scale [J].Acta Psychalr Scand,1983,67(6):361-370.
[8] 孟娜,孙秀琪,张忠娟,等.HAD 量表在老年伴有不同复杂程度心律失常患者治疗中的临床应用意义 [J].哈尔滨医药,2017,37(3):268-269.
[9] SANTOS E, COUTINHO E, MOREIRA I,et al.Epidemiology of myasthenia gravis in Northern Portugal:Frequency estimates and clinical epidemiological distribution of cases[J].Muscle Nerve,2016,54(3):413-421.
[10] ALESSANDRO C,LARA J,CAROLINE B,et al.Roland-morris disability questionnaire and oswestry disability index:which has better measurement properties for measuring physical functioning in nonspecific low back pain? Systematic review and meta-analysis[J].Phys Ther,2016,96(10):1620-1637.
[11] GOLDBERG D S,MCGEE S J.Pain as a global public health priority[J].BMC Public Health,2011,11:770.
[12] TRAN J, DORSTYN D S, BURKE A L.Psychosocial aspects of spinal cord injury pain:a meta-analysis[J].Spinal Cord,2016,54(9):640-648.
[13] CHEATLE M D.Depression,chronic pain,and suicide by overdose:on the edge[J].Pain Med,2011,12(Suppl 2):S43-S48.
[14] WONG W S,CHEN P P,YAP J,et al.Fielding R.Assessing depression in patients with chronic pain:a comparison of three rating scales[J].Affect Disord,2011,133(1/2):179-187.
[15] MORIARTY O, MCGUIRE B E, FINN D P.The effect of pain on cognitive function:a review of clinical and preclinical research[J].Prog Neurobiol,2011,93(3):385-404.
[16] WANG G Q,CEN C,LI C,et al.Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety[J].Nat Commun,2015,6:7660-7675.
[17] HSU M C, HARRIS R E, SUNDGREN P C,et al.No consistent difference in gray mattervolume between individuals with bromyalgia and age-matched healthy subjects when controlling for affective disorder[J].Pain,2009,143(3):262-267.
[18] GUSTIN S M, PECK C C, WILCOX S L,et al.Different pain,different brain:thalamic anatomy in europathic and non-neuropathic chronic pain syndromes[J].Neurosci,2011,31(16):5956-5964.
[19] GALEK A, ERBSLOH-MOLLER B, KOLLNER V,et al.Mental disorders in patients with fibromyalgia syndrome:screening in centres of different medical specialties[J].Schmerz,2013,27(3):296-304.
[20] 谢晓燕,张娟,赵莉.疼痛和抑郁共患机制的研究进展[J].中国疼痛医学杂志,2016,22(1):50-54.
[21] CIFRE I, SITGES C, FRAIMAN D,et al.Disrupted functional connectivity of the pain network in fibromyalgia[J].Psychosom Med,2012,74(1):55-62.
[22] ELSENBRUCH S, ROSENBERGER C, ENCK P,et al.Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome:an fMRI study[J].Gut,2010,59(4):489-495.
[23] DAVIDOVITCH Z, NICOLAY O, NGAN P W,et al.Neurotransmitters cytochines,and die control of alveolar bone remodelling in orthodontìcs[J].Dent Clin N Am,1988,32(3):411-435.
[24] ZYLKA M J, RICE F L, ANDERSON D J.Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd[J].Neuron,2005,45(1):17-25.
[25] JIMENEZ-ANDRADE J M, MANTYH W G, BLOOM A P,et al.The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain[J].Neurobiol Aging,2010,33(5):921-932.
[26] VELLUCCI R,TERENZI R,KANIS J A,et al.Understanding osteoporotic pain and its pharmacological treatment[J].Osteoporos Int,2018,29(7):1477-1491.
[27] EIMAR H, TAMIMI I, MURSHED M,et al.Cholinergic regulation of bone[J].Musculoskelet Neuronal Interact,2013,13(2):124-132.
[28] JUKKA P,MARI I,ZHIQI P,et al.Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model[J].Calcif Tissue Int,2008,82(2):108-115.
[29] NAGAE M, HIRAGA T, WAKABAYASHI H,et al.Osteoclasts play a part in pain due to the inflammation adjacent to bone[J].Bone,2006,39(5):1107-1115.
[30] LERNER U H, PERSSON E.Osteotropic effects by the neuropeptides calcitonin gene-related peptide,substance P and vasoactive intestinal peptide[J].Musculoskelet Neuronal Interact,2008,8(2):154-165.
[31] ABDELAZIZ D M, ABDULLAH S, MAGNUSSEN C,et al.Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta[J].Bone,2015,81:400-406.